Abstract
External Validation of a Novel Risk Model (BALL Score) in Real-World Relapsed/Refractory Chronic Lymphocytic Leukemia Patients Receiving Ibrutinib. a Campus CLL Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have